Canopy Growth (CGC) Change in Cash (2019 - 2026)
Canopy Growth (CGC) posted Change in Cash of $184.7 million for Q4 2025, up 1964.89% sequentially from $8.9 million in Q2 2025, and up 487.86% YoY from $31.4 million in Q4 2024.
Canopy Growth (CGC) Change in Cash (2019 - 2026) Analysis & Trends
Canopy Growth has reported Change in Cash for 7 years, with the latest figure at $184.7 million in Q4 2025.
- Quarterly Change in Cash rose 487.86% year-over-year to $184.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $172.6 million (up 1020.58% YoY) and the FY2026 annual result came in at $182.9 million, up 564.68% from the prior year.
- Change in Cash rose to $184.7 million in Q4 2025 per CGC's latest filing, from $8.9 million in the prior quarter.
- Over five years, Change in Cash peaked at $260.5 million in Q1 2021 and troughed at -$483.9 million in Q2 2021.
- A 5-year average of -$17.5 million and a median of $1.9 million in 2022 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2023 and 2025: Change in Cash tumbled 1995.71% in 2023, then soared 487.86% in 2025.
- Over 5 years, Change in Cash stood at -$152.7 million in 2021, then gained by 28.31% to -$109.5 million in 2022, then jumped by 32.74% to -$73.6 million in 2023, then surged by 35.33% to -$47.6 million in 2024, then jumped by 487.86% to $184.7 million in 2025.
- According to Business Quant data, Change in Cash over the past three periods registered $184.7 million, $8.9 million, and -$47.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Canopy Growth | 437.04 Mn | 190.03 Mn | 16.08 Mn | -20.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.28 Mn |
| Dec 31, 2025 | 184.66 Mn |
| Jun 30, 2025 | 8.94 Mn |
| Dec 31, 2024 | -47.61 Mn |
| Sep 30, 2024 | 26.58 Mn |
| Jun 30, 2024 | 15.98 Mn |
| Mar 31, 2024 | 20.45 Mn |
| Dec 31, 2023 | -73.62 Mn |
| Sep 30, 2023 | -216.54 Mn |
| Jun 30, 2023 | -107.01 Mn |
| Mar 31, 2023 | 58.34 Mn |
| Dec 31, 2022 | -109.47 Mn |
| Sep 30, 2022 | -17.46 Mn |
| Jun 30, 2022 | -5.11 Mn |
| Mar 31, 2022 | 126.99 Mn |
| Dec 31, 2021 | -152.70 Mn |
| Sep 30, 2021 | 196.84 Mn |
| Jun 30, 2021 | -483.90 Mn |
| Mar 31, 2021 | 260.49 Mn |
| Dec 31, 2020 | 116.34 Mn |